VON WILLEBRAND DISEASE (VWD)
Clinical trials for VON WILLEBRAND DISEASE (VWD) explained in plain language.
Never miss a new study
Get alerted when new VON WILLEBRAND DISEASE (VWD) trials appear
Sign up with your email to follow new studies for VON WILLEBRAND DISEASE (VWD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for bleeding disorder: experimental drug HMB-002 enters human testing
Disease control Recruiting nowThis study tests a new medicine, HMB-002, in 108 adults with von Willebrand disease (types 1 and 2). The goal is to check if the drug is safe, how the body processes it, and whether it helps control bleeding. Participants will receive either one or several doses of the drug, and …
Matched conditions: VON WILLEBRAND DISEASE (VWD)
Phase: PHASE1, PHASE2 • Sponsor: Hemab ApS • Aim: Disease control
Last updated May 26, 2026 05:43 UTC
-
New shot aims to stop bleeding episodes in rare blood disorder
Disease control Recruiting nowThis study tests a new medicine called VGA039, given as a shot under the skin, to prevent bleeding episodes in people with Von Willebrand disease (VWD). The trial includes 60 adolescents and adults aged 12 to 75 who have frequent bleeding (12 or more bleeds per year). The goal is…
Matched conditions: VON WILLEBRAND DISEASE (VWD)
Phase: PHASE3 • Sponsor: Vega Therapeutics, Inc • Aim: Disease control
Last updated May 26, 2026 05:37 UTC
-
Lifeline for severe bleeding disorder patients: drug access extended
Disease control AVAILABLEThis program offers continued access to an unlicensed medicine called recombinant von Willebrand factor (rVWF) for children and adults with severe von Willebrand disease who have already benefited from it in a previous study. Participants must have completed at least 12 months of…
Matched conditions: VON WILLEBRAND DISEASE (VWD)
Sponsor: Takeda • Aim: Disease control
Last updated May 26, 2026 05:37 UTC
-
New hope for rare bleeding disorder: VONVENDI trial launches in china
Disease control Recruiting nowThis study tests whether a drug called VONVENDI is safe and helps control bleeding in 20 Chinese adults with von Willebrand disease, a condition that makes blood clot poorly. Some participants may also receive ADVATE if needed. The study lasts about 14 months and includes clinic …
Matched conditions: VON WILLEBRAND DISEASE (VWD)
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated May 26, 2026 05:37 UTC
-
New study tracks Vonvendi's safety in kids with bleeding disorder
Disease control Recruiting nowThis study looks at how safe and effective the drug Vonvendi (rVWF) is for children under 18 with von Willebrand disease, a bleeding disorder. Researchers will track side effects and how well the drug controls bleeding over one year. The study is being done in Japan as part of ro…
Matched conditions: VON WILLEBRAND DISEASE (VWD)
Sponsor: Takeda • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
Scientists dive into cells to unravel bleeding disorder
Knowledge-focused Recruiting nowThis study looks at special cells from blood vessels (called ECFCs) in people with von Willebrand disease, acquired von Willebrand syndrome, and healthy volunteers. Researchers want to see how these cells make and release a key clotting protein. The goal is to better understand t…
Matched conditions: VON WILLEBRAND DISEASE (VWD)
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated May 19, 2026 11:48 UTC